• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mdm2 抑制剂 nutlin-3A 引起的细胞静止。

Cellular quiescence caused by the Mdm2 inhibitor nutlin-3A.

机构信息

Department of Cell Stress Biology, Roswell Park Cancer Institute, BLSC, Buffalo, NY, USA.

出版信息

Cell Cycle. 2009 Nov 15;8(22):3777-81. doi: 10.4161/cc.8.22.10121. Epub 2009 Nov 23.

DOI:10.4161/cc.8.22.10121
PMID:19855165
Abstract

Cellular senescence is characterized by irreversible loss of proliferative potential and a large, flat cell morphology. Ectopic p21 and doxorubicin induced cellular senescence in HT1080 and WI-38-tert cell lines. In the same cell lines, the Mdm2 inhibitor nutlin-3a induced p53 but, unexpectedly, caused quiescence (reversible arrest) with a small cell morphology. We discuss that Mdm antagonists could be used in combination with chemotherapy to reversibly arrest normal cells, thus protecting them during chemotherapy of cancer (cyclotherapy).

摘要

细胞衰老的特征是增殖能力的不可逆丧失和细胞形态的大而扁。p21 和阿霉素异位诱导 HT1080 和 WI-38-tert 细胞系的细胞衰老。在相同的细胞系中,Mdm2 抑制剂 nutlin-3a 诱导 p53,但出乎意料的是,导致静止(可逆停滞),细胞形态小。我们讨论 Mdm 拮抗剂可与化疗联合使用,可逆地阻滞正常细胞,从而在癌症化疗(cyclotherapy)期间保护它们。

相似文献

1
Cellular quiescence caused by the Mdm2 inhibitor nutlin-3A.Mdm2 抑制剂 nutlin-3A 引起的细胞静止。
Cell Cycle. 2009 Nov 15;8(22):3777-81. doi: 10.4161/cc.8.22.10121. Epub 2009 Nov 23.
2
Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells.Nutlin-3a(一种MDM2拮抗剂)激活p53可诱导成人T细胞白血病细胞发生凋亡和细胞衰老。
Leukemia. 2009 Nov;23(11):2090-101. doi: 10.1038/leu.2009.171. Epub 2009 Aug 27.
3
Intriguing novel abilities of Nutlin-3A: induction of cellular quiescence as opposed to cellular senescence--implications for chemotherapy.Nutlin-3A的有趣新功能:诱导细胞静止而非细胞衰老——对化疗的启示
Cell Cycle. 2009 Nov 15;8(22):3634-5.
4
Persistent p21 expression after Nutlin-3a removal is associated with senescence-like arrest in 4N cells.Nutlin-3a 去除后持续的 p21 表达与 4N 细胞中的衰老样阻滞有关。
J Biol Chem. 2010 Jul 23;285(30):23105-14. doi: 10.1074/jbc.M110.124990. Epub 2010 May 20.
5
Activation of p53 by nutlin-3a induces apoptosis and cellular senescence in human glioblastoma multiforme.尼拉帕尼激活 p53 诱导人胶质母细胞瘤细胞凋亡和衰老。
PLoS One. 2011 Apr 5;6(4):e18588. doi: 10.1371/journal.pone.0018588.
6
MDM-2 antagonists induce p53-dependent cell cycle arrest but not cell death in renal cancer cell lines.MDM-2 拮抗剂诱导肾癌细胞系中 p53 依赖性细胞周期阻滞而非细胞死亡。
Cancer Biol Ther. 2010 Dec 15;10(12):1315-25. doi: 10.4161/cbt.10.12.13612.
7
MDM2 inhibitor Nutlin-3a suppresses proliferation and promotes apoptosis in osteosarcoma cells.MDM2 抑制剂 Nutlin-3a 抑制骨肉瘤细胞的增殖并促进其凋亡。
Acta Biochim Biophys Sin (Shanghai). 2012 Aug;44(8):685-91. doi: 10.1093/abbs/gms053.
8
Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin.MDM2拮抗剂nutlin-3a在源自成纤维细胞的小鼠细胞中诱导p53依赖性衰老。
Cancer Res. 2007 Aug 1;67(15):7350-7. doi: 10.1158/0008-5472.CAN-07-0200.
9
Reduced transcriptional activity in the p53 pathway of senescent cells revealed by the MDM2 antagonist nutlin-3.MDM2拮抗剂Nutlin-3揭示衰老细胞p53途径中转录活性降低。
Aging (Albany NY). 2009 Sep 25;1(10):845-54. doi: 10.18632/aging.100091.
10
Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest.Mdm2是p21抑制Cdk2活性所必需的,从而有助于p53依赖的细胞周期停滞。
Mol Cell Biol. 2007 Jun;27(11):4166-78. doi: 10.1128/MCB.01967-06. Epub 2007 Mar 19.

引用本文的文献

1
Irreversible cell cycle exit associated with senescence is mediated by constitutive MYC degradation.与衰老相关的不可逆转的细胞周期退出是由组成型 MYC 降解介导的。
Cell Rep. 2023 Sep 26;42(9):113079. doi: 10.1016/j.celrep.2023.113079. Epub 2023 Aug 31.
2
Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?癌症治疗中针对p53-MDM2相互作用抑制剂的耐药机制:我们能否克服它们?
Cell Mol Biol Lett. 2021 Dec 15;26(1):53. doi: 10.1186/s11658-021-00293-6.
3
Inhibition of p53 inhibitors: progress, challenges and perspectives.
p53 抑制剂的抑制:进展、挑战和展望。
J Mol Cell Biol. 2019 Jul 19;11(7):586-599. doi: 10.1093/jmcb/mjz075.
4
Rapamycin, proliferation and geroconversion to senescence.雷帕霉素、增殖和向衰老的衰老转化。
Cell Cycle. 2018;17(24):2655-2665. doi: 10.1080/15384101.2018.1554781. Epub 2018 Dec 12.
5
p53 and metabolism: from mechanism to therapeutics.p53与新陈代谢:从机制到治疗学
Oncotarget. 2018 May 4;9(34):23780-23823. doi: 10.18632/oncotarget.25267.
6
Avoiding drug resistance through extended drug target interfaces: a case for stapled peptides.通过扩展药物靶点界面避免耐药性:关于订书肽的一个案例。
Oncotarget. 2016 May 31;7(22):32232-46. doi: 10.18632/oncotarget.8572.
7
Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity.Nutlin-3治疗可在维持骨肉瘤毒性的同时,避免顺铂诱导的骨愈合抑制。
J Orthop Res. 2016 Oct;34(10):1716-1724. doi: 10.1002/jor.23192. Epub 2016 Feb 26.
8
Mechanisms of Metastatic Tumor Dormancy.转移性肿瘤休眠的机制
J Clin Med. 2013 Sep 23;2(3):136-50. doi: 10.3390/jcm2030136.
9
Cellular senescence: from growth arrest to immunogenic conversion.细胞衰老:从生长停滞到免疫原性转变。
Age (Dordr). 2015;37(2):27. doi: 10.1007/s11357-015-9764-2. Epub 2015 Mar 20.
10
The pharmacodynamics of the p53-Mdm2 targeting drug Nutlin: the role of gene-switching noise.靶向p53-Mdm2的药物Nutlin的药效学:基因转换噪声的作用
PLoS Comput Biol. 2014 Dec 11;10(12):e1003991. doi: 10.1371/journal.pcbi.1003991. eCollection 2014 Dec.